Management of Fatigue in Primary Biliary Cholangitis Amardeep KhannaVinod S. HegadeDavid E. Jones Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) Open access 23 May 2019 Pages: 127 - 133
Portal Hypertension in NASH: Is It Different from Other Aetiologies? Sven M. FrancqueW. J. KwantenD. van der Graaff Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 14 May 2019 Pages: 134 - 143
Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Gennaro D’AmicoGiovanni Perricone Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 10 May 2019 Pages: 144 - 156
The Role of Hepatic and Splanchnic Lymphatic System in Portal Hypertension and Ascites Jordi RiberaBernat CĂłrdoba-JoverManuel Morales-Ruiz Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 16 May 2019 Pages: 157 - 163
HVPG Measurements as a Surrogate of Clinical Events in Cirrhosis: Experience from Clinical Trials Maria Gabriela DelgadoJaume Bosch Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 30 April 2019 Pages: 164 - 173
Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Mattias MandorferVirginia Hernández-GeaJuan Carlos GarcĂa-Pagán Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) Open access 02 May 2019 Pages: 174 - 186
Novel Targets and Drug Development in Portal Hypertension Robert SchierwagenSabine KleinJonel Trebicka Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) Open access 30 April 2019 Pages: 187 - 196
Patient Selection in Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Refractory Ascites and Associated Conditions Beverley KokJuan Gonzalez Abraldes Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 02 May 2019 Pages: 197 - 205
Testing for Hepatitis C in Pregnancy: the Time Has Come for Routine Rather than Risk-Based Tatyana KushnerCatherine A. ChappellArthur Y. Kim Hepatitis C (H Vargas and S Flamm, Section Editors) 09 May 2019 Pages: 206 - 215
Acute HCV Treatment: What Should We Do in the DAA Era? Zurabi LominadzeRobert S. Brown Jr Hepatitis C (H Vargas and S Flamm, Section Editors) 02 May 2019 Pages: 216 - 221
HCV Exposure in the Health Care Arena. Is there a Role for Post-exposure Prophylaxis? Ryan S. ChiangAndrew J. Muir Hepatitis C (H Vargas and S Flamm, Section Editors) 27 April 2019 Pages: 222 - 227
Hepatitis C-Positive Organs for Liver and Kidney Transplantation—Emerging Data and Current Management Strategies Blanca C. Lizaola-MayoHugo E. VargasDavid M. Chascsa Hepatitis C (H Vargas and S Flamm, Section Editors) 18 May 2019 Pages: 228 - 232
The Use of Grafts from HCV+ Patients in Transplantation: Are we There Yet? Kathy M. NillesSteven L. Flamm Hepatitis C (H Vargas and S Flamm, Section Editors) 02 May 2019 Pages: 233 - 241
State of the Art HCV Treatment in Children Christine K. LeeMaureen M. Jonas Hepatitis C (H Vargas and S Flamm, Section Editors) 17 May 2019 Pages: 242 - 248
Non-invasive Fibrosis Assessment of Patients with Hepatitis C: Application of Society Guidelines to Clinical Practice James C. ConnollyJoseph K. Lim Hepatitis C (H Vargas and S Flamm, Section Editors) 09 May 2019 Pages: 249 - 258
HCV Management in the Incarcerated Population: How Do We Deliver on This Important Front? Javier CrespoSusana LlerenaAntonio Cuadrado Hepatitis C (H Vargas and S Flamm, Section Editors) 02 May 2019 Pages: 259 - 267